Answers are grounded in this paper and cite their sources.
High exposure to certain PFAS has been associated with increased risk of kidney and testicular cancers, immune dysregulation, and metabolic disturbances, including dyslipidemia. While human exposure to PFAS is widespread, data on their accumulation in human tissues, particularly cancerous tissues, remain limited, and their role in tumor biology is poorly understood. This study examines PFAS presence and levels in surgical tumor tissues from firefighters diagnosed with cancer, probing for direct evidence on the presence of PFAS in tumor tissue. Five tumor tissues – one from a papillary kidney cancer and four from papillary thyroid cancers - were analyzed using a three-pronged approach: (i) targeted quantification of 47 target PFAS compounds by liquid-chromatography-electrospray-ionization-tandem-mass-spectrometry (LC-ESI-MS/MS), (ii) untargeted screening by high-resolution-LC-QTOF-MS/MS against a PFAS database containing ∼7000 structures, and (iii) measurement of total organic fluorine (TOF) using combustion-ion chromatography (CIC). Targeted analysis quantified 2–6 PFAS per tissue, with individual concentrations ranging from 6.1 to 362.0 ng/g and total PFAS levels from 99.3 to 920.4 ng/g. PFOA (362.0 ng/g) exhibited the highest concentration, followed by PFBS (286.0 ng/g) and PFPrA (226 ng/g). The untargeted analysis identified 12–20 species per tissue, representing a 2–6-fold increase in PFAS relative to targeted methods. Detected compounds included ultrashort-chain PFAS, fluorotelomer species, and several previously unreported PFAS classes in human tissues, including perfluoro-alcohol, perfluoroalkyl-peroxides, and perfluoroalkyl-ketones. TOF measurements in tissues from the targeted analysis accounted for 0.01–8.3 % of the total organic fluorine by CIC. This study highlights widespread and chemically diverse PFAS burden in firefighters' tumor tissues, including legacy PFAS, shorter-chain replacements, and tentatively identified fluorinated compounds. These findings emphasize the need for further research on the health risks, including thyroid cancers, of legacy and ultra-short-chain PFAS, whose toxicological profiles remain largely unexplored.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: